Why National Vision (EYE) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.
Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.
Momentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
National Vision Holdings, Inc. is one of the leading and rapidly growing optical retailers in the United States. The company holds a solid position in the attractive value segment of the U.S. optical retail industry. National Vision completed the initial public offering of its common stock in October 2017.
EYE is a Zacks Rank #3 (Hold) stock, with a Momentum Style Score of A and VGM Score of B. Shares are up 19.4% over the past one week and up 63% over the past four weeks. EYE has gained 16.4% in the last one-year period as well. Looking at trading volume, an average of 3,132,674.50 shares exchanged hands over the last 20 trading days.
A company's earnings performance is important for momentum investors as well. For fiscal 2025, three analysts revised their earnings estimate higher in the last 60 days for EYE, while the Zacks Consensus Estimate has increased $0.06 to $0.62 per share. EYE also boasts an average earnings surprise of 81.8%.
EYE should be on investors' short list because of its impressive earnings fundamentals, a good Zacks Rank, and strong Momentum and VGM Style Scores.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
National Vision Holdings, Inc. (EYE) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Oscar Health, Inc. (OSCR) Laps the Stock Market: Here's Why
Oscar Health, Inc. (OSCR) closed at $14.34 in the latest trading session, marking a +1.34% move from the prior day. This change outpaced the S&P 500's 0.38% gain on the day. At the same time, the Dow added 0.24%, and the tech-heavy Nasdaq gained 0.24%. Shares of the company witnessed a loss of 14.45% over the previous month, trailing the performance of the Finance sector with its gain of 2.88%, and the S&P 500's gain of 6.6%. The investment community will be paying close attention to the earnings performance of Oscar Health, Inc. in its upcoming release. The company's upcoming EPS is projected at $0.34, signifying a 70.00% increase compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $2.86 billion, reflecting a 28.96% rise from the equivalent quarter last year. For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $0.61 per share and a revenue of $11.21 billion, representing changes of +510% and +22.12%, respectively, from the prior year. Investors should also take note of any recent adjustments to analyst estimates for Oscar Health, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 11.11% decrease. Oscar Health, Inc. is holding a Zacks Rank of #3 (Hold) right now. Valuation is also important, so investors should note that Oscar Health, Inc. has a Forward P/E ratio of 23.07 right now. This expresses a premium compared to the average Forward P/E of 9.92 of its industry. The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 92, placing it within the top 38% of over 250 industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to follow all of these stock-moving metrics, and many more, on Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oscar Health, Inc. (OSCR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Synchronoss (SNCR) Stock Sinks As Market Gains: What You Should Know
In the latest close session, Synchronoss (SNCR) was down 2.79% at $6.96. This change lagged the S&P 500's 0.38% gain on the day. Elsewhere, the Dow gained 0.24%, while the tech-heavy Nasdaq added 0.24%. The stock of mobile services company has fallen by 5.79% in the past month, lagging the Computer and Technology sector's gain of 11.61% and the S&P 500's gain of 6.6%. Market participants will be closely following the financial results of Synchronoss in its upcoming release. On that day, Synchronoss is projected to report earnings of $0.25 per share, which would represent a year-over-year decline of 47.92%. In the meantime, our current consensus estimate forecasts the revenue to be $42.59 million, indicating a 2% decline compared to the corresponding quarter of the prior year. For the full year, the Zacks Consensus Estimates are projecting earnings of $1.17 per share and revenue of $172.42 million, which would represent changes of -28.22% and -0.68%, respectively, from the prior year. Any recent changes to analyst estimates for Synchronoss should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been a 23.91% fall in the Zacks Consensus EPS estimate. Right now, Synchronoss possesses a Zacks Rank of #5 (Strong Sell). Looking at its valuation, Synchronoss is holding a Forward P/E ratio of 6.12. This represents a discount compared to its industry average Forward P/E of 28.63. The Internet - Software industry is part of the Computer and Technology sector. With its current Zacks Industry Rank of 48, this industry ranks in the top 20% of all industries, numbering over 250. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Keep in mind to rely on to watch all these stock-impacting metrics, and more, in the succeeding trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Synchronoss Technologies, Inc. (SNCR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Duolingo, Inc. (DUOL) Outpaces Stock Market Gains: What You Should Know
In the latest close session, Duolingo, Inc. (DUOL) was up +1.63% at $481.48. This change outpaced the S&P 500's 0.38% gain on the day. On the other hand, the Dow registered a gain of 0.24%, and the technology-centric Nasdaq increased by 0.24%. Heading into today, shares of the company had lost 12.37% over the past month, lagging the Business Services sector's gain of 3.09% and the S&P 500's gain of 6.6%. The investment community will be paying close attention to the earnings performance of Duolingo, Inc. in its upcoming release. The company is predicted to post an EPS of $0.55, indicating a 7.84% growth compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $241.04 million, indicating a 35.17% increase compared to the same quarter of the previous year. For the full year, the Zacks Consensus Estimates are projecting earnings of $2.92 per share and revenue of $997.46 million, which would represent changes of +55.32% and +33.35%, respectively, from the prior year. Investors should also take note of any recent adjustments to analyst estimates for Duolingo, Inc. Recent revisions tend to reflect the latest near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Duolingo, Inc. is currently sporting a Zacks Rank of #2 (Buy). In terms of valuation, Duolingo, Inc. is presently being traded at a Forward P/E ratio of 162.12. This represents a premium compared to its industry average Forward P/E of 19.78. It is also worth noting that DUOL currently has a PEG ratio of 3.61. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. By the end of yesterday's trading, the Technology Services industry had an average PEG ratio of 1.43. The Technology Services industry is part of the Business Services sector. This industry, currently bearing a Zacks Industry Rank of 46, finds itself in the top 19% echelons of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Keep in mind to rely on to watch all these stock-impacting metrics, and more, in the succeeding trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Duolingo, Inc. (DUOL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
